ImmunityBio, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
ImmunityBio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2014 to Q2 2024.
  • ImmunityBio, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$35.3M, a 33.6% increase year-over-year.
  • ImmunityBio, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$238M, a 134% decline year-over-year.
  • ImmunityBio, Inc. annual Nonoperating Income (Expense) for 2023 was -$222M, a 236% decline from 2022.
  • ImmunityBio, Inc. annual Nonoperating Income (Expense) for 2022 was -$66M, a 237% decline from 2021.
  • ImmunityBio, Inc. annual Nonoperating Income (Expense) for 2021 was -$19.6M, a 280% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$238M -$35.3M +$17.8M +33.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$256M -$38.9M -$33.9M -678% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$222M -$148M -$125M -533% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$97M -$15.5M +$4.85M +23.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$102M -$53.1M -$37.9M -249% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$64M -$5M +$2.02M +28.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$66M -$23.4M -$11.1M -90.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$54.9M -$20.4M -$10.8M -112% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$44.1M -$15.2M -$11.7M -338% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$32.4M -$7.03M -$12.8M -221% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$19.6M -$12.3M -$10.9M -779% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 -$8.68M -$9.59M -$7.6M -381% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1.08M -$3.48M -$2.42M -229% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.34M $5.79M +$6.5M Jan 1, 2021 Mar 31, 2021 10-K 2024-03-19
Q4 2020 -$5.15M -$1.4M +$4.13M +74.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$9.28M -$1.99M -$2.48M -512% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$6.81M -$1.06M -$1.67M -271% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$5.13M -$707K -$1.12M -271% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$4.01M -$5.53M -$5.78M -2302% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $1.77M $484K +$139K +40.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.63M $616K +$193K +45.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1.43M $414K -$227K -35.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $1.66M $251K -$484K -65.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-04
Q3 2018 $2.14M $345K -$29K -7.75% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $2.17M $423K +$179K +73.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $1.99M $641K -$210K -24.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $2.2M $735K -$22K -2.91% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-25
Q3 2017 $2.23M $374K -$452K -54.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $2.68M $244K -$496K -67% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $3.17M $851K +$55K +6.91% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $3.12M $757K -$2.04M -73% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-13
Q3 2016 $5.16M $826K +$681K +470% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $4.48M $740K +$1.24M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $3.24M $796K +$1.54M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $1.7M $2.8M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $145K +$144K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$498K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$747K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 $1K* Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.